Andreas Suhrbier
10Patents
5h-index
19Co-inventors
59Inventor score
Filing activity: Jan 27, 1997 → Feb 24, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5869453A | Cytotoxic T-cell epitopes | Emerging Cross-Sectional Technologies | 10 | Expired |
| US7776343B1 | Immunogenic complexes and methods relating thereto | Human Necessities | 9 | Expired |
| US7449492B2 | Therapeutic agents—I | Emerging Cross-Sectional Technologies | 9 | Expired |
| US8173141B2 | Immunogenic complexes and methods relating thereto | Human Necessities | 5 | Active |
| US9314458B2 | Topical use of ingenol-3-angelate or a salt thereof to treat skin cancer | Emerging Cross-Sectional Technologies | 5 | Active |
| US8106092B2 | Treatment of solid cancers | Human Necessities | 2 | Expired |
| US7838555B2 | Macrocyclic diterpenes for the treatment and prophylaxis of acne vulgaris | Emerging Cross-Sectional Technologies | 1 | Expired |
| US7345026B2 | Hybrid or chimeric polynucleotides, proteins, and compositions comprising hepatitis B virus sequences | Chemistry; Metallurgy | 0 | Expired |
| US7951613B2 | Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion | Human Necessities | 0 | Active |
| US9895334B2 | Treatment of virally induced lesions | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.